Patients' costs and cost-effectiveness of tuberculosis treatment in dots and non-dots facilities in Rio de Janeiro, Brazil

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Steffen, Ricardo ^a,b   Menzies, Dick ^c   Oxlade, Olivia ^c   Pinto, Marcia ^d   de Castro, Analia Zuleika ^b   Monteiro, Paula ^b,e   Trajman, Anete ^b,e  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Rio de Janeiro Tuberculosis Scientific League   (Brazil)

^c MCGILL UNIVERSITY   (Canada)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e GAMA FILHO UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE FACILITY; HOSPITALIZATION COST; HUMAN; INCOME; INTERVIEW; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SELF CARE; SHORT COURSE THERAPY; COMMUNITY CARE; COST BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; ECONOMICS; METHODOLOGY; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; BRAZIL; COMMUNITY HEALTH SERVICES; COST-BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; QUESTIONNAIRES; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 78649519159     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014014     Document Type: Article

References (17)

1. Muniyandi M, Ramachandran R, Balasubramanian R, Narayanan PR (2006) Socio-economic dimensions of tuberculosis control: review of studies over two decades from Tuberculosis Research Center. J Commun Dis 38(3): 204-215.
2. WHO (2009) Global Tuberculosis Control: Surveillance, planning, financing. WHO Report 2009 WHO/HTM TB/2009411 Geneva, Switzerland: WHO 2009.
3. Souza FB, Villa TC, Cavalcante SC, Ruffino Netto A, Lopes LB, et al. (2007) Peculiarities of tuberculosis control in a scenario of urban violence in a disadvantaged community in Rio de Janeiro, Brazil. J Bras Pneumol 33(3): 318-322.
4. Cavalcante SC, Soares EC, Pacheco AG, Chaisson RE, Durovni B (2007) Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model. Int J Tuberc Lung Dis 11(5): 544-549.
5. Needham DM, Godfrey-Faussett P, Foster SD (1998) Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. Int J Tuberc Lung Dis 2(10): 811-817.
6. Rajeswari R, Balasubramanian R, Muniyandi M, Geetharamani S, Thresa X, et al. (1999) Socio-economic impact of tuberculosis on patients and family in India. Int J Tuberc Lung Dis 3(10): 869-877.
7. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M (2009) Drivers of tuberculosis epidemics: The role of risk factors and social determinants. Soc Sci Med.
8. Burman WJ, Dalton CB, Cohn DL, Butler JR, Reves RR (1997) A costeffectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis. Chest 112(1): 63-70.
9. Akkslip S, Rasmithat S, Maher D, Sawert H (1999) Direct observation of tuberculosis treatment by supervised family members in Yasothorn Province, Thailand. Int J Tuberc Lung Dis 3(12): 1061-1065.
10. Floyd K, Skeva J, Nyirenda T, Gausi F, Salaniponi F (2003) Cost and costeffectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi. Int J Tuberc Lung Dis 7(9 Suppl 1): S29-37.
11. Baltussen R, Floyd K, Dye C (2005) Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ 331(7529): 1364.
12. Newell JN, Baral SC, Pande SB, Bam DS, Malla P (2006) Family-member DOTS and community DOTS for tuberculosis control in Nepal: clusterrandomised controlled trial. Lancet 367(9514): 903-909.
13. Aspler A, Menzies D, Oxlade O, Banda J, Mwenge L, et al. (2008) Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, Zambia. Int J Tuberc Lung Dis 12(8): 928-935.
14. Mohan CI, Bishai D, Cavalcante S, Chaisson RE (2007) The cost-effectiveness of DOTS in urban Brazil. Int J Tuberc Lung Dis 11(1): 27-32.
15. Brazilian Ministry of Health, personal communication.
16. Hill AR, Manikal VM, Riska PF (2002) Effectiveness of directly observed therapy (DOT) for tuberculosis: a review of multinational experience reported in 1990-2000. Medicine (Baltimore) 81(3): 179-193.
17. Jacquet V, Morose W, Schwartzman K, Oxlade O, Barr G, et al. (2006) Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti. BMC Public Health 6: 209.